Long-term serologic follow-up of isolated hepatitis b core antibody in hiv-infected and hiv-uninfected women

INIS

• hepatitis 100%
• viruses 66%
• women 55%
• antibodies 55%
• antigens 50%
• humans 33%
• therapy 16%
• drugs 11%
• surfaces 11%
• hiv 11%
• levels 5%
• production 5%
• injection 5%
• increasing 5%
• receipts 5%

Medicine and Dentistry

• Woman 55%
• Antibody 50%
• Hepatitis B Core Antigen 38%
• Human Immunodeficiency Virus 33%
• Hepatitis B Antibody 33%
• Highly Active Antiretroviral Therapy 16%
• Hepatitis B Virus 16%
• Viremia 11%
• Predictor 11%
• Hepatitis C 11%
• Hepatitis B Antigen 11%
• Chronic Hepatitis C 11%
• Cell Count 11%
• Follow up 5%
• Development 5%
• Drug Use 5%
• Hepatitis B 5%
• Chemotherapeutic Agent 5%
• Drug 5%
• Hepatitis 5%
• Antibody Production 5%
• Age 5%
• Immune Disorder 5%
• Injection 5%
• Analysis 5%
• Person 5%
• Clinical Significance 5%